These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The Library Derived 4554W Peptide Inhibits Primary Nucleation of α-Synuclein. Meade RM; Morris KJ; Watt KJC; Williams RJ; Mason JM J Mol Biol; 2020 Dec; 432(24):166706. PubMed ID: 33186583 [TBL] [Abstract][Full Text] [Related]
4. Anionic lipid vesicles have differential effects on the aggregation of early onset-associated α-synuclein missense mutants. Watt KJC; Meade RM; Williams RJ; Mason JM J Biol Chem; 2022 Dec; 298(12):102565. PubMed ID: 36208776 [TBL] [Abstract][Full Text] [Related]
5. Loss in Toxic Function of Aggregates of α -Synuclein Mutants by a β-Synuclein Derived Peptide. Mohammadi S; Nikkhah M; Hosseinkhani S Protein Pept Lett; 2017; 24(8):757-764. PubMed ID: 28820063 [TBL] [Abstract][Full Text] [Related]
6. Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of α-synuclein. Rutherford NJ; Moore BD; Golde TE; Giasson BI J Neurochem; 2014 Dec; 131(6):859-67. PubMed ID: 24984882 [TBL] [Abstract][Full Text] [Related]
7. Differential phospholipid binding of alpha-synuclein variants implicated in Parkinson's disease revealed by solution NMR spectroscopy. Bodner CR; Maltsev AS; Dobson CM; Bax A Biochemistry; 2010 Feb; 49(5):862-71. PubMed ID: 20041693 [TBL] [Abstract][Full Text] [Related]
8. Unraveling amyloid formation paths of Parkinson's disease protein α-synuclein triggered by anionic vesicles. Kiskis J; Horvath I; Wittung-Stafshede P; Rocha S Q Rev Biophys; 2017 Jan; 50():e3. PubMed ID: 29233215 [TBL] [Abstract][Full Text] [Related]
9. Unveiling a Selective Mechanism for the Inhibition of α-Synuclein Aggregation by β-Synuclein. Leitao A; Bhumkar A; Hunter DJB; Gambin Y; Sierecki E Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364143 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the in vivo induction and transmission of α-synuclein pathology by mutant α-synuclein fibril seeds in transgenic mice. Rutherford NJ; Dhillon JS; Riffe CJ; Howard JK; Brooks M; Giasson BI Hum Mol Genet; 2017 Dec; 26(24):4906-4915. PubMed ID: 29036344 [TBL] [Abstract][Full Text] [Related]
11. Oligomers of Parkinson's Disease-Related α-Synuclein Mutants Have Similar Structures but Distinctive Membrane Permeabilization Properties. Stefanovic AN; Lindhoud S; Semerdzhiev SA; Claessens MM; Subramaniam V Biochemistry; 2015 May; 54(20):3142-50. PubMed ID: 25909158 [TBL] [Abstract][Full Text] [Related]
13. Alpha-synuclein stepwise aggregation reveals features of an early onset mutation in Parkinson's disease. de Oliveira GAP; Silva JL Commun Biol; 2019; 2():374. PubMed ID: 31633065 [TBL] [Abstract][Full Text] [Related]
14. N-alpha-acetylation of α-synuclein increases its helical folding propensity, GM1 binding specificity and resistance to aggregation. Bartels T; Kim NC; Luth ES; Selkoe DJ PLoS One; 2014; 9(7):e103727. PubMed ID: 25075858 [TBL] [Abstract][Full Text] [Related]
15. Small molecule-mediated stabilization of vesicle-associated helical α-synuclein inhibits pathogenic misfolding and aggregation. Fonseca-Ornelas L; Eisbach SE; Paulat M; Giller K; Fernández CO; Outeiro TF; Becker S; Zweckstetter M Nat Commun; 2014 Dec; 5():5857. PubMed ID: 25524885 [TBL] [Abstract][Full Text] [Related]
16. Pathogenic Mechanisms of Cytosolic and Membrane-Enriched α-Synuclein Converge on Fatty Acid Homeostasis. Tripathi A; Alnakhala H; Terry-Kantor E; Newman A; Liu L; Imberdis T; Fanning S; Nuber S; Ramalingam N; Selkoe D; Dettmer U J Neurosci; 2022 Mar; 42(10):2116-2130. PubMed ID: 35086904 [TBL] [Abstract][Full Text] [Related]
17. Lipidomic Analysis of α-Synuclein Neurotoxicity Identifies Stearoyl CoA Desaturase as a Target for Parkinson Treatment. Fanning S; Haque A; Imberdis T; Baru V; Barrasa MI; Nuber S; Termine D; Ramalingam N; Ho GPH; Noble T; Sandoe J; Lou Y; Landgraf D; Freyzon Y; Newby G; Soldner F; Terry-Kantor E; Kim TE; Hofbauer HF; Becuwe M; Jaenisch R; Pincus D; Clish CB; Walther TC; Farese RV; Srinivasan S; Welte MA; Kohlwein SD; Dettmer U; Lindquist S; Selkoe D Mol Cell; 2019 Mar; 73(5):1001-1014.e8. PubMed ID: 30527540 [TBL] [Abstract][Full Text] [Related]
18. Vesicle trafficking and lipid metabolism in synucleinopathy. Fanning S; Selkoe D; Dettmer U Acta Neuropathol; 2021 Apr; 141(4):491-510. PubMed ID: 32607605 [TBL] [Abstract][Full Text] [Related]
19. Cell models of lipid-rich α-synuclein aggregation validate known modifiers of α-synuclein biology and identify stearoyl-CoA desaturase. Imberdis T; Negri J; Ramalingam N; Terry-Kantor E; Ho GPH; Fanning S; Stirtz G; Kim TE; Levy OA; Young-Pearse TL; Selkoe D; Dettmer U Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20760-20769. PubMed ID: 31548371 [TBL] [Abstract][Full Text] [Related]